The DOI matches its Crossref record; 229 of the 243 references it cites were found in a registry or an index.
Leber congenital amaurosis due to RPE65 mutations and its treatment with gene therapy
Open accessAbstract
Leber congenital amaurosis (LCA) is a rare hereditary retinal degeneration caused by mutations in more than a dozen genes. RPE65, one of these mutated genes, is highly expressed in the retinal pigment epithelium where it encodes the retinoid isomerase enzyme essential for the production of chromophore which forms the visual pigment in rod and cone photoreceptors of the retina. Congenital loss of chromophore production due to RPE65-deficiency together with progressive photoreceptor degeneration cause severe and progressive loss of vision. RPE65-associated LCA recently gained recognition outside of specialty ophthalmic circles due to early success achieved by three clinical trials of gene therapy using recombinant adeno-associated virus (AAV) vectors. The trials were built on multitude of basic, pre-clinical and clinical research defining the pathophysiology of the disease in human subjects and animal models, and demonstrating the proof-of-concept of gene (augmentation) therapy. Substantial gains in visual function of clinical trial participants provided evidence for physiologically relevant biological activity resulting from a newly introduced gene. This article reviews the current knowledge on retinal degeneration and visual dysfunction in animal models and human patients with RPE65 disease, and examines the consequences of gene therapy in terms of improvement of vision reported.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“For RPE65 the severity of disease has been associated with the degree of residual enzymatic activity.274,281,557”
From Chemistry of the Retinoid (Visual) Cycle (2014) · cites this paper as [274]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“RPE65 catalyses the conversion of all-trans-retinyl ester to 11-cis-retinol, allowing it to be reused in phototransduction and preventing its conversion to potentially toxic molecules.”
From The Role of Vitamin A in Retinal Diseases (2022) · cites this paper as [109]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In addition, retinyl esters accumulate in the RPE, leading to its damage [7,108,109,110].”
From The Role of Vitamin A in Retinal Diseases (2022) · cites this paper as [109]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The pathogenesis, therefore, combines local vitamin A deficiency and its impaired metabolism, which leads to the formation of toxic byproducts.”
From The Role of Vitamin A in Retinal Diseases (2022) · cites this paper as [109]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Pathogenic variants in RPE65 result in 11-cis-retinol and subsequently 11-cis-retinal deficiency, which essentially stops the visual cycle.”
From The Role of Vitamin A in Retinal Diseases (2022) · cites this paper as [109]
The check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“Dysfunction of such processes as phagocytosis, lysosomal degradation, and removal of waste products by the RPE can lead to severe retinopathies, including age-related macular degeneration (AMD).”
From Chemistry of the Retinoid (Visual) Cycle (2014) · cites this paper as [274]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Huang, D., Swanson, E. A., Lin, C. P., Schuman, J. S., Stinson, W. G., Chang, W., Hee, M. R., Flotte, T., Gregory, K. W., Puliafito, C. A., et al. (1991) · Science · doi:10.1126/science.1957169 · Cited by 14,001
Receptive fields of single neurones in the cat's striate cortex
Hubel, D. H., & Wiesel, T. N. (1959) · The Journal of Physiology · doi:10.1113/jphysiol.1959.sp006308 · Cited by 4,653
Human photoreceptor topography
Curcio, C. A., Sloan, K. R., Kalina, R. E., & Hendrickson, A. E. (1990) · The Journal of Comparative Neurology · doi:10.1002/cne.902920402 · Cited by 2,894
New Visual Acuity Charts for Clinical Research
Ferris, F. L., Kassoff, A., Bresnick, G. H., & Bailey, I. L. (1982) · American Journal of Ophthalmology · doi:10.1016/0002-9394(82)90197-0 · Cited by 2,147
Safety and Efficacy of Gene Transfer for Leber's Congenital Amaurosis
Maguire, A. M., Simonelli, F., Pierce, E. A., Pugh, E. N., Mingozzi, F., Bennicelli, J., Banfi, S., Marshall, K. A., Testa, F., Surace, E. M., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0802315 · Cited by 2,145
Experience-dependent structural synaptic plasticity in the mammalian brain
Holtmaat, A., & Svoboda, K. (2009) · Nature Reviews Neuroscience · doi:10.1038/nrn2699 · Cited by 1,934
Effect of gene therapy on visual function in Leber’s congenital amaurosis
Bainbridge, J. W. B., Smith, A. J., Barker, S. S., Robbie, S., Henderson, R., Balaggan, K., Viswanathan, A., Holder, G. E., Stockman, A., Tyler, N., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0802268 · Cited by 1,924
Milner, A. D., & Goodale, M. A. (2008) · Neuropsychologia · doi:10.1016/j.neuropsychologia.2007.10.005 · Cited by 1,514
The Major Cell Populations of the Mouse Retina
Jeon, C.-J., Strettoi, E., & Masland, R. H. (1998) · The Journal of Neuroscience · doi:10.1523/jneurosci.18-21-08936.1998 · Cited by 1,429
Hattar, S., Lucas, R. J., Mrosovsky, N., Thompson, S., Douglas, R. H., Hankins, M. W., Lem, J., Biel, M., Hofmann, F., Foster, R. G., et al. (2003) · Nature · doi:10.1038/nature01761 · Cited by 1,245
Research works printed but not linked: 1
- Gal, 1998, Mutation spectrum of RPE65 in autosomal recessive childhood-onset severe retinal dystrophy, Investig. Ophthalmol. Vis. Sci., 39, S901
Cited by
Sorted by citations
Current clinical applications of in vivo gene therapy with AAVs
Mendell, J. R., Al-Zaidy, S. A., Rodino-Klapac, L. R., Goodspeed, K., Gray, S. J., Kay, C. N., Boye, S. L., Boye, S. E., George, L. A., Salabarria, S., et al. (2021) · Molecular Therapy · doi:10.1016/j.ymthe.2020.12.007 · Cited by 743
Engineered Virus-like Particles for Efficient in Vivo Delivery of Therapeutic Proteins
Banskota, S., Raguram, A., Suh, S., Du, S. W., Davis, J. R., Choi, E. H., Wang, X., Nielsen, S. C., Newby, G. A., Randolph, P. B., et al. (2022) · Cell · doi:10.1016/j.cell.2021.12.021 · Cited by 668
Jacobson, S. G. (2012) · Archives of Ophthalmology · doi:10.1001/archophthalmol.2011.298 · Cited by 639
High, K. A., & Roncarolo, M. G. (2019) · New England Journal of Medicine · doi:10.1056/nejmra1706910 · Cited by 555
Cideciyan, A. V., Jacobson, S. G., Beltran, W. A., Sumaroka, A., Świder, M., Iwabe, S., Román, A. J., Olivares, M. B., Schwartz, S., Komáromy, A. M., et al. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1218933110 · Cited by 441
Self-citationDias, M. F., Joo, K., Kemp, J. A., Fialho, S. L., Silva‐Cunha, A., Woo, S. J., & Kwon, Y. J. (2017) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2017.10.004 · Cited by 437
Maguire, A. M., Russell, S., Wellman, J. A., Chung, D. C., Yu, Z.-F., Tillman, A., Wittes, J., Pappas, J., Elci, O., Marshall, K. A., et al. (2019) · Ophthalmology · doi:10.1016/j.ophtha.2019.06.017 · Cited by 409
Chemistry of the Retinoid (Visual) Cycle
Kiser, P. D., Golczak, M., & Palczewski, K. (2014) · Chemical Reviews · doi:10.1021/cr400107q · Cited by 353
Testa, F., Maguire, A. M., Rossi, S., Pierce, E. A., Melillo, P., Marshall, K. A., Banfi, S., Surace, E. M., Sun, J., Acerra, C., et al. (2013) · Ophthalmology · doi:10.1016/j.ophtha.2012.11.048 · Cited by 331
Han, H., Li, S., Xu, M., Zhong, Y., Fan, W., Xu, J., Zhou, T., Ji, J., Ye, J., & Yao, K. (2023) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2023.114770 · Cited by 341
A comprehensive review of retinal gene therapy
Boye, S. E., Boye, S. L., Lewin, A. S., & Hauswirth, W. W. (2013) · Molecular Therapy · doi:10.1038/mt.2012.280 · Cited by 262
Beltran, W. A., Cideciyan, A. V., Lewin, A. S., Iwabe, S., Khanna, H., Sumaroka, A., Chiodo, V. A., Fajardo, D. S., Román, A. J., Deng, W.-T., et al. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1118847109 · Cited by 260
Self-citationNeuroprotective strategies for retinal disease
Pardue, M. T., & Allen, R. S. (2018) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2018.02.002 · Cited by 237
Yu-Wai-Man, P., Newman, N. J., Carelli, V., Moster, M. L., Biousse, V., Sadun, A. A., Klopstock, T., Vignal-Clermont, C., Sergott, R. C., Rudolph, G., et al. (2020) · Science Translational Medicine · doi:10.1126/scitranslmed.aaz7423 · Cited by 232
Biology and therapy of inherited retinal degenerative disease: insights from mouse models
Veleri, S., Lazar, C. H., Chang, B., Sieving, P. A., Banin, E., & Swaroop, A. (2015) · Disease Models & Mechanisms · doi:10.1242/dmm.017913 · Cited by 253
Clinical Perspective: Treating RPE65-Associated Retinal Dystrophy
Maguire, A. M., Bennett, J., Aleman, E. M., Leroy, B. P., & Alemán, T. S. (2020) · Molecular Therapy · doi:10.1016/j.ymthe.2020.11.029 · Cited by 189
Jang, H., Jo, D. H., Cho, C. S., Shin, J. H., Seo, J. H., Yu, G., Gopalappa, R., Kim, D., Cho, S., Kim, J. H., et al. (2021) · Nature Biomedical Engineering · doi:10.1038/s41551-021-00788-9 · Cited by 186
Key enzymes of the retinoid (visual) cycle in vertebrate retina
Kiser, P. D., Golczak, M., Maeda, A., & Palczewski, K. (2012) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2011.03.005 · Cited by 177
Garafalo, A. V., Cideciyan, A. V., Héon, E., Sheplock, R., Pearson, A., WeiYang Yu, C., Sumaroka, A., Aguirre, G. D., & Jacobson, S. G. (2020) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2019.100827 · Cited by 173
Self-citationEndoplasmic reticulum stress and the unfolded protein responses in retinal degeneration
Zhang, S. X., Sanders, E. N., Fliesler, S. J., & Wang, J. J. (2014) · Experimental Eye Research · doi:10.1016/j.exer.2014.04.015 · Cited by 152
Structural Characterization of the Dual Glycan Binding Adeno-Associated Virus Serotype 6
Ng, R., Govindasamy, L., Gurda, B. L., McKENNA, R. V., Kozyreva, O. G., Samulski, R. J., Parent, K. N., Baker, T. S., & Agbandje‐McKenna, M. (2010) · Journal of Virology · doi:10.1128/jvi.01235-10 · Cited by 148
RPGR: Its role in photoreceptor physiology, human disease, and future therapies
Megaw, R. D., Soares, D. C., & Wright, A. F. (2015) · Experimental Eye Research · doi:10.1016/j.exer.2015.06.007 · Cited by 146
Restoration of visual function by transplantation of optogenetically engineered photoreceptors
Garita‐Hernandez, M., Lampič, M., Chaffiol, A., Guibbal, L., Routet, F., Santos‐Ferreira, T., Gasparini, S. J., Borsch, O., Gagliardi, G., Reichman, S., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-12330-2 · Cited by 123
Cideciyan, A. V., Rachel, R. A., Alemán, T. S., Świder, M., Schwartz, S., Sumaroka, A., Román, A. J., Stone, E. M., Jacobson, S. G., & Swaroop, A. (2011) · Human Molecular Genetics · doi:10.1093/hmg/ddr022 · Cited by 117
Self-citationBanin, E., Gootwine, E., Obolensky, A., Ezra-Elia, R., Ejzenberg, A., Zelinger, L., Honig, H., Rosov, A., Yamin, E., Sharon, D., et al. (2015) · Molecular Therapy · doi:10.1038/mt.2015.114 · Cited by 113
Human CRB1 -Associated Retinal Degeneration: Comparison with the rd8 Crb1 -Mutant Mouse Model
Alemán, T. S., Cideciyan, A. V., Aguirre, G. K., Huang, W., Mullins, C. L., Román, A. J., Sumaroka, A., Olivares, M. B., Tsai, F. F., Schwartz, S., et al. (2011) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.11-7701 · Cited by 116
Self-citationAnimal Models of Retinal Disease
Fletcher, E. L., Jobling, A. I., Vessey, K. A., Luu, C. D., Guymer, R. H., & Baird, P. N. (2011) · Progress in molecular biology and translational science · doi:10.1016/b978-0-12-384878-9.00006-6 · Cited by 111
The Role of Vitamin A in Retinal Diseases
Sajovic, J., Meglič, A., Glavač, D., Markelj, Š., Hawlina, M., & Fakin, A. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23031014 · Cited by 109
Retinoids and Retinal Diseases
Kiser, P. D., & Palczewski, K. (2016) · Annual Review of Vision Science · doi:10.1146/annurev-vision-111815-114407 · Cited by 108
Gérard, X., Perrault, I., Hanein, S., Silva, E. D., Bigot, K., Defoort‐Dhellemmes, S., Rio, M., Münnich, A., Scherman, D., Kaplan, J., et al. (2012) · Molecular Therapy — Nucleic Acids · doi:10.1038/mtna.2012.21 · Cited by 106
Targeting Nonsense Mutations in Diseases with Translational Read-Through-Inducing Drugs (TRIDs)
Nagel‐Wolfrum, K., Möller, F., Penner, I., Baasov, T., & Uwe Wolfrum, B. (2016) · BioDrugs · doi:10.1007/s40259-016-0157-6 · Cited by 101
Jo, D. H., Song, D. W., Cho, C. S., Kim, U. G., Lee, K. J., Lee, K., Park, S. W., Kim, J., Kim, J. H., Kim, J., et al. (2019) · Science Advances · doi:10.1126/sciadv.aax1210 · Cited by 101
Koch, S., Sothilingam, V., Garrido, M. G., Tanimoto, N., Bećirović, E., Koch, F., Seide, C., Beck, S. C., Seeliger, M. W., Biel, M., et al. (2012) · Human Molecular Genetics · doi:10.1093/hmg/dds290 · Cited by 97
Structural insights into adeno-associated virus serotype 5
Govindasamy, L., DiMattia, M. A., Gurda, B. L., Halder, S., McKenna, R., Chiorini, J. A., Muzyczka, N., Zolotukhin, S., & Agbandje-McKenna, M. (2013) · Journal of Virology · doi:10.1128/jvi.00867-13 · Cited by 95
Why is the dog an ideal model for aging research?
Gilmore, K. M., & Greer, K. A. (2015) · Experimental Gerontology · doi:10.1016/j.exger.2015.08.008 · Cited by 101
Retinal pigment epithelium 65 kDa protein (RPE65): An update
Kiser, P. D. (2021) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2021.101013 · Cited by 100
Leber’s Congenital Amaurosis: Current Concepts of Genotype-Phenotype Correlations
Huang, C.-H., Yang, C., Yang, C., Hou, Y., & Chen, T. (2021) · Genes · doi:10.3390/genes12081261 · Cited by 95
Therapeutic Potential of Small Molecules and Engineered Proteins
Gurevich, E. V., & Gurevich, V. V. (2013) · Handbook of experimental pharmacology · doi:10.1007/978-3-642-41199-1_1 · Cited by 99
Beltran, W. A., Cideciyan, A. V., Iwabe, S., Świder, M., Kosyk, M. S., McDaid, K. S., Martynyuk, I., Ying, G., Shaffer, J., Deng, W., et al. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1509914112 · Cited by 94
Self-citationBoth Ends of the Leash — The Human Links to Good Dogs with Bad Genes
Ostrander, E. A. (2012) · New England Journal of Medicine · doi:10.1056/nejmra1204453 · Cited by 92
Leveraging Zebrafish to Study Retinal Degenerations
Angueyra, J. M., & Kindt, K. S. (2018) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2018.00110 · Cited by 85
OTX2 loss causes rod differentiation defect in CRX-associated congenital blindness
Roger, J. E., Hiriyanna, A., Gotoh, N., Hong, H., Cheng, D. F., Ratnapriya, R., Kautzmann, M.-A. I., Chang, B., & Swaroop, A. (2014) · Journal of Clinical Investigation · doi:10.1172/jci72722 · Cited by 79
Advances in gene therapy for diseases of the eye
Petit, L., Khanna, H., & Punzo, C. (2016) · Human Gene Therapy · doi:10.1089/hum.2016.040 · Cited by 82
BEST1 gene therapy corrects a diffuse retina-wide microdetachment modulated by light exposure
Guziewicz, K. E., Cideciyan, A. V., Beltran, W. A., Komáromy, A. M., Dufour, V., Świder, M., Iwabe, S., Sumaroka, A., Kendrick, B. T., Ruthel, G. T., et al. (2018) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1720662115 · Cited by 84
Self-citationTreatment Possibilities for Retinitis Pigmentosa
Jacobson, S. G., & Cideciyan, A. V. (2010) · New England Journal of Medicine · doi:10.1056/nejmcibr1007685 · Cited by 78
Self-citationTherapeutic promise of engineered nonsense suppressor tRNAs
Porter, J. J., Heil, C. S., & Lueck, J. D. (2021) · Wiley Interdisciplinary Reviews - RNA · doi:10.1002/wrna.1641 · Cited by 73
Molecular pharmacodynamics of emixustat in protection against retinal degeneration
Zhang, J., Kiser, P. D., Badiee, M., Palczewska, G., Dong, Z., Golczak, M., Tochtrop, G. P., & Palczewski, K. (2015) · Journal of Clinical Investigation · doi:10.1172/jci80950 · Cited by 75
Koirala, A., Makkia, R. S., Conley, S. M., Cooper, M. J., & Naash, M. I. (2013) · Human Molecular Genetics · doi:10.1093/hmg/ddt013 · Cited by 75
Long-term Structural Outcomes of Late-stage RPE65 Gene Therapy
Gardiner, K. L., Cideciyan, A. V., Swider, M., Dufour, V. L., Sumaroka, A., Komáromy, A. M., Hauswirth, W. W., Iwabe, S., Jacobson, S. G., Beltran, W. A., et al. (2020) · Molecular Therapy · doi:10.1016/j.ymthe.2019.08.013 · Cited by 67
Self-citationHow genetic errors in GPCRs affect their function: Possible therapeutic strategies
Stoy, H., & Gurevich, V. V. (2015) · Genes & Diseases · doi:10.1016/j.gendis.2015.02.005 · Cited by 77
Scholl, H. P. N., Moore, A. T., Koenekoop, R. K., Wen, Y., Fishman, G. A., van den Born, L. I., Bittner, A., Bowles, K., Fletcher, E. C., Collison, F. T., et al. (2015) · PLOS ONE · doi:10.1371/journal.pone.0143846 · Cited by 71
Retinyl ester hydrolases and their roles in vitamin A homeostasis
Schreiber, R., Taschler, U., Preiss-Landl, K., Wongsiriroj, N., Zimmermann, R., & Lass, A. (2011) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2011.05.001 · Cited by 72
Emerging approaches for restoration of hearing and vision
Kleinlogel, S., Vogl, C., Jeschke, M., Neef, J., & Moser, T. (2020) · Physiological Reviews · doi:10.1152/physrev.00035.2019 · Cited by 74
Therapeutic Challenges to Retinitis Pigmentosa: From Neuroprotection to Gene Therapy
Sahni, J., Angi, M., Irigoyen, C., Angi, M., Semeraro, F., Romano, M., Parmeggiani, F., & Parmeggiani, F. (2011) · Current Genomics · doi:10.2174/138920211795860062 · Cited by 69
Banin, E., Bandah‐Rozenfeld, D., Obolensky, A., Cideciyan, A. V., Alemán, T. S., Marks-Ohana, D., Sela, M. N., Boye, S. L., Sumaroka, A., Román, A. J., et al. (2010) · Human Gene Therapy · doi:10.1089/hum.2010.047 · Cited by 69
Self-citationLeber Congenital Amaurosis (LCA): Potential for Improvement of Vision
Cideciyan, A. V., & Jacobson, S. G. (2019) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.19-26672 · Cited by 69
Self-citationWang, X., Yu, C., Tzekov, R. T., Zhu, Y., & Li, W. (2020) · Orphanet Journal of Rare Diseases · doi:10.1186/s13023-020-1304-1 · Cited by 68
Chemistry and Biology of the Initial Steps in Vision: The Friedenwald Lecture
Palczewski, K. (2014) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.14-15502 · Cited by 70
RPGR- Associated Retinal Degeneration in Human X-Linked RP and a Murine Model
Huang, W. C., Wright, A. F., Román, A. J., Cideciyan, A. V., Manson, F. D. C., Gewaily, D. Y., Schwartz, S., Sadigh, S., Limberis, M. P., Bell, P. L., et al. (2012) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.12-10070 · Cited by 65
Self-citationMembrane-binding and enzymatic properties of RPE65
Kiser, P. D., & Palczewski, K. (2010) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2010.03.002 · Cited by 62
Sengillo, J. D., Gregori, N. Z., Sisk, R. A., Weng, C. Y., Berrocal, A. M., Davis, J. L., Mendoza‐Santiesteban, C. E., Zheng, D. D., Feuer, W. J., & Lam, B. L. (2021) · Ophthalmology Retina · doi:10.1016/j.oret.2021.11.005 · Cited by 63
Jacobson, S. G., Cideciyan, A. V., Alemán, T. S., Sumaroka, A., Román, A. J., Świder, M., Schwartz, S., Banin, E., & Stone, E. M. (2010) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.10-6127 · Cited by 63
Self-citationCoppieters, F., Schil, K. V., Bauwens, M., Verdin, H., Jaegher, A. D., Syx, D., Sante, T., Lefever, S., Abdelmoula, N. B., Depasse, F., et al. (2014) · Genetics in Medicine · doi:10.1038/gim.2014.24 · Cited by 62
Jo, D. H., Jang, H., Cho, C. S., Han, J. H., Ryu, G., Jung, Y., Bae, S., & Kim, J. H. (2022) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2022.11.021 · Cited by 61
Dog Models for Blinding Inherited Retinal Dystrophies
Petersen‐Jones, S. M., & Komáromy, A. M. (2015) · Human Gene Therapy Clinical Development · doi:10.1089/humc.2014.155 · Cited by 62
Jacobson, S. G., Cideciyan, A. V., Sumaroka, A., Román, A. J., Charng, J., Lu, M., Choi, W., Sheplock, R., Świder, M., Kosyk, M. S., et al. (2017) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.17-21560 · Cited by 58
Self-citationCellular and Molecular Mechanisms of Pathogenesis Underlying Inherited Retinal Dystrophies
Manley, A., Meshkat, B. I., Jablonski, M. M., & Hollingsworth, T. (2023) · Biomolecules · doi:10.3390/biom13020271 · Cited by 61
Retinal transduction profiles by high-capacity viral vectors
Puppo, A., Cesi, G., Marrocco, E., Piccolo, P., Jacca, S., Shayakhmetov, D. M., Parks, R. J., Davidson, B. L., Colloca, S., Brunetti‐Pierri, N., et al. (2014) · Gene Therapy · doi:10.1038/gt.2014.57 · Cited by 61
Gene therapy provides long-term visual function in a pre-clinical model of retinitis pigmentosa
Wert, K. J., Davis, R. J., Sancho-Pellúz, J., Nishina, P. M., & Tsang, S. H. (2012) · Human Molecular Genetics · doi:10.1093/hmg/dds466 · Cited by 57
Optogenetic Approaches to Restoring Vision
Pan, Z., Lu, Q., Bi, A., Dizhoor, A. M., & Abrams, G. W. (2015) · Annual Review of Vision Science · doi:10.1146/annurev-vision-082114-035532 · Cited by 56
A History of the Classical Visual Cycle
Wright, C. B., Redmond, T. M., & Nickerson, J. M. (2015) · Progress in molecular biology and translational science · doi:10.1016/bs.pmbts.2015.06.009 · Cited by 52
Gene Therapy of Inherited Retinopathies: A Long and Successful Road from Viral Vectors to Patients
Colella, P., & Auricchio, A. (2012) · Human Gene Therapy · doi:10.1089/hum.2012.123 · Cited by 54
Cwerman-Thibault, H., Augustin, S., Ellouze, S., Sahel, J.-A., & Corral-Debrinski, M. (2014) · Comptes Rendus. Biologies · doi:10.1016/j.crvi.2013.11.011 · Cited by 49
Preventing Neurodegeneration by Controlling Oxidative Stress: The Role of OXR1
Volkert, M. R., & Crowley, D. J. (2020) · Frontiers in Neuroscience · doi:10.3389/fnins.2020.611904 · Cited by 46
Sun, D., Sahu, B., Gao, S., Schur, R. M., Vaidya, A. M., Maeda, A., Palczewski, K., & Lu, Z.-R. (2017) · Molecular Therapy - Nucleic Acids · doi:10.1016/j.omtn.2017.02.005 · Cited by 47
Prime Editing for Human Gene Therapy: Where Are We Now?
Godbout, K., & Tremblay, J. P. (2023) · Cells · doi:10.3390/cells12040536 · Cited by 56
TULP1 Mutations Causing Early-Onset Retinal Degeneration: Preserved but Insensitive Macular Cones
Jacobson, S. G., Cideciyan, A. V., Huang, W., Sumaroka, A., Román, A. J., Schwartz, S., Luo, X., Sheplock, R., Dauber, J. M., Świder, M., et al. (2014) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.14-14570 · Cited by 47
Self-citationCao, H., Machuca, T., Yeung, J. C., Wu, J., Du, K., Duan, C., Hashimoto, K., S, V. L., Coates, A. L., Leung, K., et al. (2013) · Molecular Therapy — Nucleic Acids · doi:10.1038/mtna.2013.55 · Cited by 45
Tang, P. H., Buhusi, M. C., Ma, J.-X., & Crouch, R. K. (2011) · The Journal of Neuroscience · doi:10.1523/jneurosci.4265-11.2011 · Cited by 45
Sallum, J. M. F., Kaur, V. P., Shaikh, J., Banhazi, J., Spera, C., Aouadj, C., Viriato, D., & Fischer, M. D. (2022) · Advances in Therapy · doi:10.1007/s12325-021-02036-7 · Cited by 47
Gene therapy for Leber congenital amaurosis: advances and future directions
Hufnagel, R. B., Ahmed, Z. M., Corrêa, Z. M., & Sisk, R. A. (2012) · Graefe s Archive for Clinical and Experimental Ophthalmology · doi:10.1007/s00417-012-2028-2 · Cited by 46
Bouaita, A., Augustin, S., Lechauve, C., Cwerman‐Thibault, H., Bénit, P., Simonutti, M., Pâques, M., Rustin, P., Sahel, J., & Corral‐Debrinski, M. (2011) · Brain · doi:10.1093/brain/awr290 · Cited by 43
Dinculescu, A., Estreicher, J., Zenteno, J. C., Alemán, T. S., Schwartz, S., Huang, W., Román, A. J., Sumaroka, A., Li, Q., Deng, W., et al. (2011) · Human Gene Therapy · doi:10.1089/hum.2011.169 · Cited by 43
Self-citationRetiGene, a comprehensive gene atlas for inherited retinal diseases
Rivolta, C., Çelik, E., Kamdar, D., Cancellieri, F., Kamińska, K., Ullah, M., Barberán-Martínez, P., Bouckaert, M., Cortón, M., Delanote, E., et al. (2025) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2025.08.017 · Cited by 42
QLT091001, a 9-cis-Retinal Analog, Is Well-Tolerated by Retinas of Mice with Impaired Visual Cycles
Maeda, T., Dong, Z., Jin, H., Sawada, O., Gao, S., Utkhede, D., Monk, W., Palczewska, G., & Palczewski, K. (2013) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.12-11152 · Cited by 41
Lecithin:Retinol Acyltransferase: A Key Enzyme Involved in the Retinoid (visual) Cycle
Sears, A. E., & Palczewski, K. (2016) · Biochemistry · doi:10.1021/acs.biochem.6b00319 · Cited by 40
Retinal optogenetic therapies: clinical criteria for candidacy
Jacobson, S. G., Sumaroka, A., Luo, X., & Cideciyan, A. V. (2013) · Clinical Genetics · doi:10.1111/cge.12165 · Cited by 39
Self-citationHealth Services Utilization and Cost of Retinitis Pigmentosa
Frick, K. D., Roebuck, M. C., Feldstein, J. I., McCarty, C. A., & Grover, L. L. (2012) · Archives of Ophthalmology · doi:10.1001/archophthalmol.2011.2820 · Cited by 40
Choi, E. H., Suh, S., Sander, C. L., Hernandez, C. J. O., Bulman, E. R., Khadka, N., Dong, Z., Shi, W., Palczewski, K., & Kiser, P. D. (2018) · Human Molecular Genetics · doi:10.1093/hmg/ddy128 · Cited by 38
Sumaroka, A., Garafalo, A. V., Semenov, E. P., Sheplock, R., Krishnan, A. K., Román, A. J., Jacobson, S. G., & Cideciyan, A. V. (2019) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.19-27156 · Cited by 38
Self-citationRecent Advances in the Biology, Therapy and Management of Melanoma
Davids, L. M. (2013) · InTech eBooks · doi:10.5772/46052 · Cited by 38
Disease mechanisms of X-linked retinitis pigmentosa due to RP2 and RPGR mutations
Lyraki, R., Megaw, R. D., & Hurd, T. W. (2016) · Biochemical Society Transactions · doi:10.1042/bst20160148 · Cited by 37
Defining Outcomes for Clinical Trials of Leber Congenital Amaurosis Caused by GUCY2D Mutations
Jacobson, S. G., Cideciyan, A. V., Sumaroka, A., Román, A. J., Charng, J., Lu, M., Choudhury, S., Schwartz, S., Héon, E., Fishman, G. A., et al. (2017) · American Journal of Ophthalmology · doi:10.1016/j.ajo.2017.02.003 · Cited by 36
Self-citationFukuda, S., Nagano, M., Yamashita, T., Kimura, K., Tsuboi, I., Salazar, G. T., Ueno, S., Kondo, M., Kunath, T., Oshika, T., et al. (2013) · Stem Cells · doi:10.1002/stem.1469 · Cited by 35
Jung, G., Sun, J., Petrowitz, B., Riecken, K., Kruszewski, K., Jankowiak, W., Kunst, F., Skevas, C., Richard, G. W., Fehse, B., et al. (2013) · Stem Cells Translational Medicine · doi:10.5966/sctm.2013-0013 · Cited by 35
Intervisit Variability of Visual Parameters in Leber Congenital Amaurosis Caused by RPE65 Mutations
Román, A. J., Cideciyan, A. V., Schwartz, S., Olivares, M. B., Héon, E., & Jacobson, S. G. (2013) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.12-11341 · Cited by 35
Self-citationLi, S., Xiao, X., Yi, Z., Sun, W., Wang, P., & Zhang, Q. (2019) · Acta Ophthalmologica · doi:10.1111/aos.14181 · Cited by 36
Myosin7a Deficiency Results in Reduced Retinal Activity Which Is Improved by Gene Therapy
Colella, P., Sommella, A., Marrocco, E., Di Vicino, U., Polishchuk, E., Garrido, M. G., Seeliger, M. W., Polishchuk, R., & Auricchio, A. (2013) · PLoS ONE · doi:10.1371/journal.pone.0072027 · Cited by 34
Retinal amino acid neurochemistry in health and disease
Kalloniatis, M., Loh, C. S., Acosta, M. L., Tomisich, G., Zhu, Y., Nivison‐Smith, L., Fletcher, E. L., Chua, J., Sun, D., & Arunthavasothy, N. (2013) · Clinical and Experimental Optometry · doi:10.1111/cxo.12015 · Cited by 36
Advancements in CRISPR/Cas systems for disease treatment
Xu, Y., Le, H., Wu, Q., Wang, N., & Gong, C. (2025) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2025.05.007 · Cited by 35
Metadata
- Authors
- Cideciyan, A. V.
- Affiliations
- University of Pennsylvania (US)
- Corresponding author
- Cideciyan, Artur V.
- ORCID
- Cideciyan, Artur V.
- Venue
- Progress in Retinal and Eye Research
- Publisher
- Elsevier BV
- Published
- 2010-09
- Volume
- 29
- Issue
- 5
- Pages
- 398-427
- ISSN
- 1350-9462 (ISSN-L)
- PMC
- PMC2903652
- OpenAlex
- W1970654757
- Cited by
- 256
- References
- 243
- Citations by year
- 2026: 10 · 2025: 15 · 2024: 13 · 2023: 11 · 2022: 13 · 2021: 18 · 2020: 14 · 2019: 19 · 2018: 10 · 2017: 12 · 2016: 11 · 2015: 21 · 2014: 18 · 2013: 22 · 2012: 23
- FWCI
- 1.99
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Progress in Retinal and Eye Research (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Eye Institute (U10EY017280, R01EY013203)
- Topics
- Health Sciences › Medicine › Ophthalmology › Retinal Development and Disorders
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Virus-based gene therapy research
- Health Sciences › Medicine › Ophthalmology › Retinal Diseases and Treatments
- Keywords
- Leber congenital amaurosis, RPE65 mutations, gene therapy, recombinant adeno-associated virus vectors, retinal pigment epithelium, photoreceptor degeneration, inherited retinal degeneration, animal models, visual function outcomes
- MeSH terms
- Retinoid Isomerohydrolase, Animals, Carrier Proteins, DNA, Eye Proteins, Humans, Mutation, Genetic Therapy, cis-trans-Isomerases, Leber Congenital Amaurosis
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
